Ukusinda Komdlavuza Wesibindi 2026: Ukwelashwa Nezindleko ZaseChina - Izibhedlela Eziseduze Nami 

Ukusinda komdlavuza wesibindi ngo-2026 ibone ukuthuthuka okukhulu ngenxa yempumelelo yezindlela zokwelapha ze-neoadjuvant kanye nemihlahlandlela yomtholampilo ebuyekeziwe evela e-China. Ucwaningo lwakamuva lubonisa ukuthi inhlanganisela yemithi emisha enikezwa ngaphambi kokuhlinzwa ingacishe iphindwe kabili isikhathi iziguli eziphila ngaso ngaphandle kokubuya kwesifo, kuguqule izinga lokunakekelwa komhlaba wonke.

Ukuphumelela Kwamazinga Okusinda Komdlavuza Wesibindi 2026

I-landscape ye-hepatocellular carcinoma (HCC) kanye ne-intrahepatic cholangiocarcinoma (ICC) yokwelashwa ishintshe kakhulu ekuqaleni kuka-2026. Emashumini eminyaka, umdlavuza wesibindi wawuhlotshaniswa nokubikezela okubi kanye namazinga aphezulu wokuphindaphinda. Nokho, Ukusinda komdlavuza wesibindi amamethrikhi manje achazwa kabusha ngokuhlolwa komtholampilo okuqinile okuvela ezikhungweni zezokwelapha ezinkulu zase-China.

Ucwaningo olubalulekile olushicilelwe ku I-New England Journal of Medicine ngoMashi 2026 igqamisa ushintsho lwepharadigm. Iholwa abacwaningi baseSibhedlela saseZhongshan saseFudan University, lolu cwaningo oluhlanganisa izikhungo eziningi lubonise ukuthi umthetho olandelwayo othize we-neoadjuvant unganweba ukusinda okungenamicimbi okumaphakathi kusuka ezinyangeni eziyi-8.7 kuye kweziyi-18. Lokhu kufanekisela ukuphindwa cishe kabili kwesikhathi iziguli ezihlala zingenawo umdlavuza obuyayo ngemva kokwelashwa.

Ukubaluleka kwale datha akukwazi ukweqiwa. Ngokomlando, izinga lokusinda leminyaka emihlanu ngemva kokuhlinzwa komdlavuza othile wesibindi laliphakathi kwama-25% nama-40%. Ukuhlanganiswa kokwelashwa okuhlosiwe kanye ne-immunotherapy ngaphambi kokuhlinzwa kuba ngokushesha "izinga lokunakekelwa" elisha leziguli ezifanele. Le ndlela inciphisa izimila ngokuphawulekayo ngaphambi kokuba ummese uthinte isikhumba, ngezinga lokuphendula eliqondile lifinyelela cishe ku-55% emaqenjini okulinga.

Abashayeli Ababalulekile Bokusinda Okuthuthukisiwe

• I-Neoadjuvant Protocols: Ukuphatha i-systemic therapy ngaphambi kokuhlinzwa ukuze kwehle izimila.
• Ukuhlanganiswa kwe-Immunotherapy: Ukusebenzisa i-PD-1/PD-L1 inhibitors ukuze kusebenze amasosha omzimba ngokumelene nesifo esincanyana.
• Ukukhomba Ngokunemba: Ukuhlanganisa i-chemotherapy ne-tyrosine kinase inhibitors (TKIs) ethile.
• Ukutholwa Kusenesikhathi: Ukuhlolwa okuthuthukisiwe okuholela emathubeni okungenelela angaphambili.

Lokhu kuthuthukiswa akukhawulelwe kuzilungiselelo zokuhlola. NgoJanuwari 2026, Ikhomishini Yezempilo Kazwelonke YaseChina yakhipha i- Izinkombandlela Zokuhlonza Umdlavuza Wesibindi kanye Nezokwelapha (Ushicilelo luka-2026). Lo mbhalo uhlanganisa ubufakazi bekhwalithi ephezulu, okuhlanganisa nocwaningo lwasekhaya lwangempela olushicilelwe kumajenali aphezulu wamazwe ngamazwe, olunikeza isiqondiso esigunyaziwe sezobuchwepheshe sokusebenza komtholampilo ezweni lonke.

Izinkombandlela Zomtholampilo zase-China zango-2026 kanye Nokuvumelana Kochwepheshe

Ukukhishwa kweziqondiso zika-2026 kuphawula ingqopha-mlando ekulweni nomdlavuza wesibindi emhlabeni wonke. Ngokungafani nokuphindaphinda okwedlule, inguqulo ka-2026 ihlanganisa ngokusobala okutholwe kwakamuva okuvela esikhathini "okuhlosiwe kanye nokuzivikela komzimba". Kudlulela ngale kwezigaba ezilula ze-anatomical ukufaka izici zengozi yezinto eziphilayo, iqinisekisa ukuthi ukwelashwa kuhambisana namathuba esiguli ngasinye okuphinda kwenzeke.

Idokhumenti engumngane, i Ukuvumelana Kochwepheshe Ngokwelashwa Kwe-Adjuvant Kwangemva Kokuhlinzwa Kwe-Hepatocellular Carcinoma (Ushicilelo luka-2026), yaphinde yethulwa eShanghai. Iholwa izifundiswa u-Fan Jia no-Zhou Jian, lokhu kuvumelana kudingida udaba olunenkani lokuphindaphinda kwangemva kokuhlinzwa, oluthinta ama-50% kuya ku-70% eziguli. Ukuvumelana kunikeza uhlaka oluhlelekile lokuhlonza iziguli “ezisengozini ephakathi nendawo ukuya kweziphezulu” ezizuza kakhulu ekwelashweni kwe-adjuvant.

Ukuhlelwa Kwengozi Yokuphindeka

Ukuvumelana kwango-2026 kwethula indlela ethuthukisiwe yokuhlukanisa ingozi yokuphinda. Lokhu kuhlukaniswa kubalulekile ekunqumeni ukuthi isiguli sidinga ukwelashwa kwe-adjuvant okunolaka noma singaphathwa ngokugadwa okujwayelekile.

• Ingcuphe Yokuvela Kwangaphambi Kwesikhashana (≤2 iminyaka): Kuchazwa izici ezifana nezimila eziningi, ubukhulu bobubanzi obukhulu kuno-5 cm, i-Edmondson grade III-IV, ukuhlasela kwe-microvascular noma macrovascular, i-lymph node metastasis, ukuphuka kwesimila, nokungajwayelekile okuqhubekayo kwe-AFP noma i-DCP ngemva kokuhlinzwa.
• Ingozi Yokuvela Kamuva (>iminyaka engu-2): Ngokuvamile kuhlotshaniswa nokuqhubekela phambili kwesifo sesibindi kune-tumor biology yasekuqaleni.
• Isu Lengozi Ephansi: Iziguli ezinethumba elilodwa ≤5 cm futhi okungekho ukuhlasela kwe-microvascular ziyelulekwa ukuthi zihlole njalo ukulandelwa kunokwelashwa kwe-adjuvant ngokushesha.

Lokhu kukhiyelwa ngokuqondile emaqenjini “aphakathi-kuya-phezulu” kuqinisekisa ukuthi izindlela zokwelapha ezinamandla zigcinelwe labo abazidinga kakhulu, kuthuthukisa ukwabiwa kwezinsiza kanye nokunciphisa imiphumela emibi engadingekile kubantu abasengozini encane. Iziqondiso zigcizelela ukuthi ukwelashwa kwe-systemic anti-tumor kungene esigabeni esisha lapho isisindo saso esimweni se-adjuvant senyuke kakhulu.

I-Neoadjuvant Therapy: Izinga Elisha Lokunakekela

Umqondo wokwelapha nge-neoadjuvant—ukwelapha umdlavuza ngaphambi kokungenelela okuyinhloko kokuhlinzwa—uphumelele ekuhlolweni kuya kokubalulekile ngo-2026. Isivivinyo esiyingqopha-mlando esibandakanya iziguli eziyi-178 kuzo zonke izibhedlela eziyi-11 eShayina sinikeze ubufakazi obuqinile obudingekayo ukuze kuqiniswe le ndlela yokwenza.

Kulolu cwaningo, iqembu elilodwa lathola imijikelezo emithathu ye-Gemox chemotherapy ehlanganiswe nomuthi wokwelapha ohlosiwe kanye ne-ejenti ye-immunotherapy. Iqembu elilawulayo lahlinzwa ngokushesha, okwakuyindinganiso evamile. Imiphumela yayicacile: ukusinda ngaphandle kwemicimbi emaphakathi kweqembu elihlanganisa izidakamizwa kwakuyizinyanga eziyi-18, uma kuqhathaniswa nezinyanga eziyi-8.7 kuphela zeqembu elihlinzayo kuphela.

Indlela yokwenza isenzo

Impumelelo yale cocktail ilele ekuhlaseleni kwayo okunezinhlangothi eziningi kwesimila. I-Chemotherapy ibulala ngokuqondile amangqamuzana ahlukana ngokushesha. Imithi yokwelapha ehlosiwe ivimbela izindlela ezithile ezibangela ukukhula kwesimila kanye ne-angiogenesis (ukwakheka kwemithambo yegazi). Izidakamizwa ze-Immunotherapy, njenge-PD-1 inhibitors, zisiza amasosha omzimba ukubona futhi ahlasele amangqamuzana omdlavuza okungenzeka agweme ukutholwa.

Ngokunciphisa isimila ngaphambi kokuhlinzwa, odokotela abahlinzayo bangakwazi ukuthola amamajini acacile (ukukhishwa kabusha kwe-R0), okuyisibikezelo esibalulekile sokuphila isikhathi eside. Ngaphezu kwalokho, ukwelapha ama-micrometastase kusenesikhathi kuwavimbela ekusunguleni ezinye izingxenye zesibindi noma umzimba ngesikhathi sokucindezeleka kokuhlinzwa.

Izinyathelo Zokusebenzisa Emtholampilo

• Isinyathelo 1: Ukuxilongwa kanye Nezigaba: I-imaging ephelele kanye ne-biopsy yokuqinisekisa i-HCC noma i-ICC nokunquma isigaba.
• Isinyathelo sesi-2: Ukuhlolwa kobungozi: Linganisa ukuhlasela kwemithambo, usayizi wesimila, namazinga e-biomarker (AFP, DCP).
• Isinyathelo sesi-3: Ukubuyekezwa kwethimba le-Multidisciplinary (MDT): Odokotela abahlinzayo, ama-oncologists, nama-radiologists bayasebenzisana ukuze banqume ngokufaneleka kwe-neoadjuvant.
• Isinyathelo sesi-4: I-Neoadjuvant Administration: Imvamisa imijikelezo emi-3 yokwelashwa okuhlangene emavikini angama-6-9.
• Isinyathelo sesi-5: Ukuhlaziya kabusha: Ukufanekisa ukuhlola ukuncipha kwesimila kanye nokusabela.
• Isinyathelo sesi-6: Ukukhishwa kabusha kokuhlinzwa: Ukuqhubeka nokuhlinzwa uma isimila siphindeka futhi isimo sesiguli sivuma.

Lokhu kugeleza komsebenzi manje sekwamukelwa izibhedlela ezihamba phambili hhayi e-China kuphela kodwa kunomthelela kumaphrothokholi emhlabeni jikelele. Ikhono lokuguqula izigameko ezingalungiseki zibe ezikwazi ukuphinda ziphindeke ngokuhlehlisa libaluleke kakhulu ezigulini ezinamathumba amakhulu noma ayinkimbinkimbi.

Amasu Okwelashwa Kwe-Adjuvant Kwangemva Kokuhlinzwa

Ngisho nangemva kokuhlinzwa okuyimpumelelo, ingozi yokuphinda iphinde ibe yisithiyo esiyinhloko isikhathi eside Ukusinda komdlavuza wesibindi. I-2026 Expert Consensus inikeza izincomo ezinemininingwane yokwelashwa kwe-adjuvant, ukusuka endleleni "yokulingana-konke" ukuya emuthini onembayo.

I-Systemic Therapy kusilungiselelo se-Adjuvant

Ukuvumelana kugqamisa ukungena kokwelashwa okuhleliwe “enkathini yamasosha omzimba ahlosiwe.” Idatha evela ezifundweni ezibandakanya i-sintilimab ne-atezolizumab kanye ne-bevacizumab (uhlobo lwe-“T+A”) inyuse isisindo sokwelashwa kwe-systemic esigabeni se-adjuvant.

• Inhlanganisela Amathrendi: Ubufakazi buphakamisa ukuthi ukuhlanganisa izidakamizwa ezihlosiwe (njenge-donafenib) ne-immunotherapy (njenge-tislelizumab noma i-toripalimab) kungase kuthuthukise ukubikezela kweziguli ezisengozini enkulu.
• I-Immunotherapy Monotherapy: Ezigulini ezinezici zokuphinda zibe sengozini ephakathi kuya kwephezulu, ama-immune checkpoint inhibitors ewodwa abonise izinzuzo ezibalulekile Ekuphileni Okungabuyeli Ukubuyela emuva (RFS).
• Ubude besikhathi: Ukuvumelana kuncoma izinyanga eziyisi-6 kuye kweziyi-12 zokwelashwa kwe-systemic anti-tumor ezigulini ezisengozini enkulu.

Ngokuphawulekayo, i-donafenib monotherapy yeziguli ezisengcupheni enkulu ibonise izinga lokusinda lonyaka ongu-1 lokuphinda lifinyelele kuma-87%. Kumasethi esiguli athile, inhlanganisela yemithi yehlise izinga lokusinda lonyaka ongu-1 laya ku-96.7%. Lezi zibalo zimelela ukweqa okukhulu okuvela kudatha yomlando.

Ukulungiswa Kokwelashwa Kwasendaweni

Ngaphandle kwemithi ye-systemic, ukwelashwa kwendawo kudlala indima ebalulekile ekuqedeni izifo ezisele. Imihlahlandlela yango-2026 ihlanganisa futhi icwengisise izinkomba ze-Transarterial Chemoembolization (TACE), Hepatic Arterial Infusion Chemotherapy (HAIC), kanye nokwelashwa ngemisebe.

• I-Adjuvant TACE: Inconyelwe iziguli ezisengozini enkulu cishe inyanga eyodwa ngemva kokuhlinzwa, ngokuvamile okuhlanganisa izifundo ezi-1 kuya kwezi-2.
• I-Adjuvant HAIC: Icaciselwe ngokukhethekile iziguli ezine-Microvascular Invasion (MVI). I-HAIC yangemva kokuhlinzwa isebenzisa uhlobo lwe-FOLFOX ithuthukisa kakhulu i-RFS kuleli qembu elincane.
• Ukwelashwa kwemisebe: I-Intensity-Modulated Radiation Therapy (IMRT) ifakwe kuhlu njengethuluzi eliyinhloko leziguli ezinemajini amancane okuhlinza (≤1 cm), i-MVI positivity, noma i-thrombus ye-portal vein ehlanganisiwe. Inciphisa kakhulu ingozi yokuphindaphinda kwemajini.

Lokhu kungenelela kwasendaweni kuklanyelwe ukukhomba umbhede wesibindi lapho kungenzeka khona ukuphinda kwenzeke, okusebenza njengenethi yokuphepha eduze kwezindlela zokwelapha ezihlelekile.

Amasistimu Wesiteji Athuthukile: Isibuyekezo se-BCLC 2026

Uhlelo lwesiteji lwe-Barcelona Clinic Liver Cancer (BCLC) luhlala luwuhlaka olusetshenziswa kakhulu emhlabeni jikelele. Isibuyekezo sango-2026 sigcina unxantathu waso oyinhloko wesiteji, ukubikezela, nokwelashwa kodwa sethula isendlalelo sokwenza izinqumo esishintshashintshayo: uhlaka lwe-CUSE.

I-CUSE Decision Framework

Isibuyekezo sika-2026 BCLC sihlanganisa Ubunkimbinkimbi, Ukungaqiniseki, Ukuzithoba, kanye Nemizwa (CUSE) ekwenzeni izinqumo zomtholampilo. Lokhu kuvuma ukuthi ukwelapha umdlavuza wesibindi akukhona nje ukulandela i-algorithm esekelwe kusayizi wesimila; kuhilela ukuzulazula kuwebhu eyinkimbinkimbi yezinto eziqondene nesiguli.

• Ubunkimbinkimbi: Ukwamukela izimo zezifo eziningi kanye nokutholakala kwezinketho eziningi zokwelapha.
• Ukungaqiniseki: Ukubhekana nokungaqondakali okubikezelwayo kanye nokuphindaphindwa okuqhubekayo kobufakazi bezokwelapha.
• Isihloko: Ukubalwa kwezimali komehluko ngamunye kanye nezintandokazi zabasebenzi bezokwelapha neziguli.
• Umzwelo: Kucatshangelwa okuhlangenwe nakho kwangaphambilini, okulindelwe, nezinkolelo zomuntu siqu zethimba lokunakekela nesiguli.

Lolu hlaka luqondisa ama-Multidisciplinary Teams (MDT) ukuthi enze izinqumo zesayensi, ezigxile esigulini. Iqinisekisa ukuthi ukwelashwa "okungcono kakhulu" ephepheni kuhambisana neqiniso lempilo yesiguli, amanani, kanye nokugcinwa komzimba.

Izincomo Zokwelashwa Ngesiteji

Ukufakwa kwe-SBRT kanye ne-TARE njengezinye izindlela zokwelapha iziguli ezisesigabeni sangaphambi kwesikhathi kunweba ibhokisi lamathuluzi kulabo abangazohlinzwa noma bakhishwe ngenxa yendawo yesimila noma ukugula okuhambisana nakho. Khonamanjalo, isexwayiso esiphathelene nokwelashwa okuhlangene okujwayelekile eSigabeni B sibonisa ukuzibophezela ekwenzeni okusekelwe ebufakazini, ukugwema ukweqisa kuze kutholakale idatha eyengeziwe.

Abantu Abakhethekile: Ukufakelwa kanye Nokukhishwa

Ukuvumelana kwango-2026 kuphinde kudingidwe izimo ezikhethekile ezivame ukuxabanisa ukuphathwa komdlavuza wesibindi, ikakhulukazi ukufakelwa kwesibindi kanye nokwelashwa kwe-ablation.

I-Liver Transplantation Protocols

Ezigulini ezifakelwa isibindi, ukukhetha uhlobo lomuthi we-immunosuppressive kubalulekile. Ukuvumelana kuphakamisa ukusetshenziswa kwe-mTOR inhibitors (njenge-sirolimus noma i-everolimus) njengomgogodla wokuzivikela komzimba. Ngokungafani ne-calcineurin inhibitors, ama-mTOR inhibitors abonwe anezindawo zokulwa nesimila, okungenzeka asize ekwehliseni ubungozi bokuphinda umdlavuza ngemuva kokufakelwa.

I-Ablation Therapy

Nakuba ubufakazi obuphezulu bokwelashwa kwe-adjuvant ikakhulukazi ngemva kokukhishwa kwe-ablation busaqongelela, kuphawula ukuvumelana ukuthi izidakamizwa ezihlosiwe noma ze-immunotherapy zingase zicatshangelwe ezigulini ezisengozini enkulu ezilahlekelwa yi-ablation. Njengoba kunikezwe ukuthi ukukhipha i-ablation kuvame ukusetshenziselwa izimila ezincane, iphrofayili yengozi iyahluka ekukhishweni okukhulu, kodwa isimiso sokubhekana nesifo se-micrometastatic sihlala sibalulekile kulabo abanezici ezimbi ze-pathological.

Ukuphathwa Okuphelele kanye Nokwelashwa Kwamagciwane

Isici esibalulekile, esivame ukunganakwa sokuthuthukisa Ukusinda komdlavuza wesibindi ukuphathwa kwesifo sesibindi esingaphansi. Imihlahlandlela yango-2026 igcizelela ukuthi ukwelashwa okuyisisekelo kwesizinda sesibindi kubalulekile kuzo zonke iziguli.

Ama-Antiviral Imperatives

Ezigulini ezinomdlavuza wesibindi ohlobene ne-Hepatitis B Virus (HBV), ukusetshenziswa impilo yonke ye-nucleoside analogs (njenge-tenofovir noma i-entecavir) kuyimpoqo emva kokuhlinzwa. Ukucindezela ukuphindaphinda kwegciwane kunciphisa ukuvuvukala, kuvimbela ukubola kwesibindi, futhi kwehlisa ingozi ye-de novo carcinogenesis ezicutshini zesibindi ezisele.

Iqhaza Lemithi Yesintu Yesimanje

Ekuhlanganisweni okuphawulekayo kwemithi yendabuko neyesimanje, ukuvumelana kuncoma ukusetshenziswa kwe-Huaier granules ngemva kokuhlinzwa okukhulu. Ukuhlolwa komtholampilo kuphakamisa ukuthi lokhu kulungiselelwa komuthi waseShayina wesimanje kungasiza ekuvimbeleni ukuphindeka futhi kunwebe ukusinda kukonke, kunikeze isendlalelo esengeziwe sokuvikela iziguli ezilulamayo.

Amaphrothokholi Okuqapha Athuthukisiwe

Amasu okulandelela athuthukisiwe, ikakhulukazi emaqenjini asengozini ephakathi ukuya kwephezulu. Isincomo esokulandelelwa okungenani njalo ngemva kwezinyanga ezintathu. Ngale kwe-imaging evamile (CT noma i-MRI), imihlahlandlela iphakamisa ukuthi lapho izimo zivuma, ubuchwepheshe be-liquid biopsy obufana nama-Circulating Tumor Cells (CTC) kanye ne-circulating tumor DNA (ctDNA) kufanele kusetshenziswe.

• Ukuqapha kwe-CTC/ctDNA: Lawa mathuluzi angathola izimpawu zamangqamuzana zokuphindaphinda izinyanga ngaphambi kokuba zibonakale kumaskeni, okuvumela ukungenelela kwangaphambi kwesikhathi.
• Ukulandelela i-Biomarker: Ukuqapha njalo amazinga e-AFP kanye ne-DCP kusalokhu kuyinsika yokubhekwa.

Ukuthola Izibhedlela Nezikhungo Zokwelapha Eziseduze Nawe

Ukufinyelela ekunakekelweni okukhethekile kuyisici esinqumayo emiphumeleni yokusinda. Iziguli ezifuna izinqubo zakamuva, okuhlanganisa nemithi ye-neoadjuvant kanye nemithi yokwelapha ethuthukisiwe yendawo echazwe ngenhla, kufanele ibheke izikhungo ezineminyango ezinikele ye-hepatobiliary oncology.

Okufanele Ukubheke Esibhedlela

• Ithimba le-Multidisciplinary Team (MDT): Qinisekisa ukuthi isibhedlela sinenqubo esemthethweni ye-MDT lapho odokotela abahlinzayo, odokotela bezokwelapha, odokotela be-radioologist, kanye nodokotela bezifo bebuyekeza amacala ndawonye.
• Ukufinyelela Kwesivivinyo Somtholampilo: Izibhedlela ezisezingeni eliphezulu zivame ukubamba iqhaza ezivivinyweni zomtholampilo zomhlaba wonke noma zikazwelonke, zinikeza ukufinyelela emithini esezingeni eliphezulu ngaphambi kokuba itholakale kabanzi.
• Ubuchwepheshe obuthuthukisiwe: Ukutholakala kwe-SBRT, i-HAIC, kanye namasu okuhlinza asezingeni eliphezulu afana ne-laparoscopic noma ukukhishwa kwesibindi okurobhothi.
• Ivolumu nolwazi: Izikhungo ezinomthamo omkhulu ngokuvamile zibika amazinga angcono ezinkinga kanye nemiphumela yokusinda ekuhlinzweni kwesibindi okuyinkimbinkimbi.

E-China, izikhungo ezifana ne-Fudan University's Zhongshan Hospital, i-Cancer Hospital of the Chinese Academy of Medical Sciences, kanye ne-First Affiliated Hospital ye-USTC zihola phambili ekusebenziseni le mihlahlandlela ka-2026. Emazweni omhlaba, iziguli kufanele zifune izikhungo zomdlavuza eziqokwe yi-NCI noma izibhedlela zasenyuvesi ezinezinhlelo eziqinile ze-hepatobiliary.

Ukucatshangelwa Kwezindleko Nokufinyeleleka

Nakuba intuthuko yezokwelapha ngo-2026 iyathembisa, izindleko zisalokhu zikhathaza kakhulu iziguli eziningi. Ukushintshela ekuhlanganisweni kwe-immunotherapy kanye nokwelashwa okuhlosiwe kungakhuphula umthwalo wezezimali wokwelashwa.

Umshwalense kanye Nokuvikela

E-China, izidakamizwa eziningi ezinconyiwe, okuhlanganisa ama-PD-1 inhibitors asekhaya kanye nama-TKIs, zifakwe kukhathalogi kazwelonke yomshwalense wezokwelapha, okwehlisa kakhulu izindleko eziphuma ephaketheni leziguli. Lesi sinyathelo senqubomgomo sibalulekile ekuqinisekiseni ukuthi "isixazululo sikazwelonke" sokuvimbela nokulawula umdlavuza wesibindi sifinyeleleka kubantu abaningi.

Emhlabeni jikelele, ukuhlinzekwa kuyehluka ngezwe kanye nomhlinzeki womshwalense. Iziguli zikhuthazwa ukuthi:

• Xhumana nabeluleki bezezimali basesibhedlela ngaphambi kwenqubo yokuhlela ukwelashwa.
• Phenya ngezinhlelo zokusiza iziguli ezihlinzekwa yizinkampani ezithaka imithi.
• Hlola ukufaneleka kokuhlolwa komtholampilo, okuvamise ukukhokhela izindleko zemithi yophenyo kanye nokuhlola okuhlobene.

Umthelela Wezomnotho Wesikhathi Eside

Kubalulekile ukubuka izindleko zokwelashwa kumongo wokuphila isikhathi eside. Izindlela zokwelapha ezisebenzayo ze-neoadjuvant kanye ne-adjuvant ezivimbela ukuphindeka zingagcina zinciphise izindleko eziphelele zokunakekelwa ngokugwema ukwelapha okubizayo kokuhlenga, ukulaliswa esibhedlela okuphindaphindiwe, nokunakekelwa kwe-palliative okuhambisana nesifo esithuthukile, esiphindelelayo.

Izikhombisi-ndlela zesikhathi esizayo kanye nocwaningo oluqhubekayo

Umkhakha wokwelashwa komdlavuza wesibindi uthuthuka ngesivinini esingakaze sibonwe. Imihlahlandlela yango-2026 iyisithombe esifushane solwazi lwamanje, kodwa ucwaningo lusaqhubeka nokuphusha imingcele. Ukuthunyelwa kwakamuva eMhlanganweni Waminyaka Yonke ka-2026 we-ASCO okuvela ezikhungweni ezifana neSibhedlela sase-Zhongnan kugqamisa imingcele evelayo.

Ubuchwepheshe obuqhamukayo

• I-Lattice Radiotherapy: Ihlola ukuphepha nokusebenza ngempumelelo kwe-Lattice Stereotactic Flash Radiotherapy yezimila zesibindi ezinkulu ezingabaleki (≥10 cm).
• Amagciwane e-Ocolytic: Izivivinyo zesigaba sokuqala ziphenya imijovo ye-intratumoral elandelanayo yamagciwane anoveli e-oncolytic ahlanganiswe namanye ama-ejenti wamathumba aqinile athuthukile.
• I-Metallic Death Induction: Ucwaningo lwama-metabolites afana ne-alpha-ketoglutarate enza i-ferroptosis (ukufa kweseli elincike ku-iron) ukuthuthukisa ukuzwela komsakazo kumdlavuza wesisu.

Lezi zinguquko ziphakamisa ukuthi incazelo ye Ukusinda komdlavuza wesibindi izoqhubeka nokwenza ngcono. Ukuhlanganiswa kwemininingwane yokuhlela kabusha i-metabolic kanye namasu esizukulwane esilandelayo semisebe kuthembisa ukubhekana nezinhlobo zesifo ezimelana kakhulu.

Isiphetho: Inkathi Entsha Yethemba

Unyaka ka-2026 uphawula inguquko empini yokulwa nomdlavuza wesibindi. Ngokushicilelwa kwemihlahlandlela kazwelonke ebuyekeziwe, ukuqinisekiswa kwemithi yokwelapha eyinhlanganisela ye-neoadjuvant, kanye nokucolisiswa kwamamodeli okuhlelwa kwengozi, iziguli namuhla zinezinketho eziphumelela kakhulu kunangaphambili. Ukucishe kuphindeke kabili kokusinda okungenamicimbi ezivivinyweni zakamuva kunikeza ithemba elibambekayo lapho kwake kwaba khona ithuba elilinganiselwe.

Kusukela ekusetshenzisweni okunembile kwemithi “ehlosiwe kanye namasosha omzimba” kuya ekulawuleni okuphelele kwesifo sesibindi esicashile, indlela eya phambili icacile. Impumelelo incike ekutholweni kusenesikhathi, ekufinyeleleni ekunakekelweni okukhethekile kwemikhakha eminingi, kanye nokuhambisana nemithethonqubo yakamuva esekelwe ebufakazini. Njengoba ucwaningo luqhubeka nokuveza ubunkimbinkimbi bebhayoloji yomdlavuza wesibindi, umkhondo we Ukusinda komdlavuza wesibindi amaphuzu aya phezulu kancane kancane, eguqula isifo esike saba yingozi kakhulu sibe isimo esilawulekayo, futhi esivame ukulapheka.

Iziguli nemindeni bayakhuthazwa ukuthi bahlanganyele ngokugcwele namathimba abo okunakekelwa kwezempilo, babuze mayelana nemihlahlandlela yakamuva, futhi bahlole zonke izindlela zokwelashwa ezitholakalayo. Ukuhlangana kochwepheshe bezokwelapha baseShayina nokusebenzisana kwesayensi yomhlaba wonke kuye kwakha uhlaka oluqinile lokunqoba umdlavuza wesibindi, isiguli esisodwa ngesikhathi.